EMG
DPLO

Ellington Management Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Ellington Management Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-21,200
Closed -$129K – 883
2019
Q2 		$129K Sell
21,200
-600
-3% -$3.19K 0.02% 535
2019
Q1 		$127K Buy
+21,800
New +$225K 0.02% 519
2017
Q3 		– Sell
-17,100
Closed -$253K – 948
2017
Q2 		$253K Buy
+17,100
New +$285K 0.04% 464
2016
Q4 		– Sell
-10,300
Closed -$289K – 905
2016
Q3 		$289K Buy
+10,300
New +$346K 0.08% 442

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ellington Management Group's DPLO Position: Q3 2019 in Review

Ellington Management Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2019, closing a stake of 21,200 shares — an estimated $129K sold.

Ellington Management Group first reported a position in DPLO in Q3 2016 and held it in 4 quarters. The position peaked at $289K in Q3 2016. 137 funds tracked by Wall St. Rank hold DPLO as of Q3 2019.

  • Ellington Management Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2019 after selling out during the quarter.
  • Ellington Management Group sold 21,200 DIPLOMAT PHARMACY, INC. shares in Q3 2019, an estimated $129K.
  • Ellington Management Group first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 4 quarters.
  • Ellington Management Group's DIPLOMAT PHARMACY, INC. position peaked at $289K in Q3 2016.
  • 137 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2019.

Based on Ellington Management Group's 13F filing for Q3 2019, filed 14 Nov 2019.